Amin Sanjiv B, Guillet Ronnie
Department of Pediatrics, Golisano Children's Hospital at Strong, University of Rochester, Rochester, New York, USA.
Pediatrics. 2007 Mar;119(3):502-8. doi: 10.1542/peds.2006-2174.
Our goal was to determine if multiple courses of antenatal betamethasone affect auditory neural maturation in 28 to 32 weeks' gestational age infants.
A retrospective cohort study was performed to compare auditory neural maturation between premature infants exposed to 1 course of betamethasone and infants exposed to > or = 2 courses of betamethasone. Inclusion criteria included all 28 to 32 weeks' gestational age infants delivered between July 1996 and December 1998 who had auditory brainstem response testing performed (80-dB click stimuli at a repetition rate of 39.9/second) within 24 hours of postnatal life as part of bilirubin-auditory studies. Infants with toxoplasmosis, rubella, cytomegalovirus, herpes infections, chromosomal disorders, unstable conditions, exposure to antenatal dexamethasone, and exposure to < 1 complete course of betamethasone were excluded. Auditory waveforms were categorized into response types on response replicability and peak identification as types 1 through 4 (type 1 indicating most mature). Absolute and interpeak wave latencies were measured when applicable. Categorical and continuous variables were analyzed by using the chi2 test and Student's t test, respectively.
Of 174 infants studied, 123 received antenatal steroids. Of these, 50 received 1 course and 29 received > or = 2 courses of betamethasone. There were no significant differences in perinatal demographics between the 2 groups. After controlling for confounding variables, there was no significant difference in mean absolute wave latencies, mean interpeak latencies, or distribution of response type between the 2 groups. There also was no significant difference in any auditory brainstem response parameters between infants exposed to 1 course of betamethasone (n = 50) and infants exposed to > 2 courses of betamethasone (n = 17).
Compared with a single recommended course of antenatal steroids, multiple courses of antenatal betamethasone are not associated with a deleterious effect on auditory neural maturation in 28 to 32 weeks' gestational age infants.
我们的目标是确定多疗程产前倍他米松是否会影响孕28至32周婴儿的听觉神经成熟度。
进行了一项回顾性队列研究,以比较接受1疗程倍他米松治疗的早产儿与接受≥2疗程倍他米松治疗的早产儿的听觉神经成熟度。纳入标准包括1996年7月至1998年12月期间分娩的所有孕28至32周的婴儿,这些婴儿在出生后24小时内作为胆红素-听觉研究的一部分进行了听觉脑干反应测试(80分贝短声刺激,重复率为39.9/秒)。排除患有弓形虫病、风疹、巨细胞病毒、疱疹感染、染色体疾病、病情不稳定、产前接触地塞米松以及接受少于1个完整疗程倍他米松治疗的婴儿。根据反应的可重复性和峰值识别情况,将听觉波形分为1至4型(1型表示最成熟)。在适用时测量绝对波潜伏期和峰间潜伏期。分别使用卡方检验和学生t检验分析分类变量和连续变量。
在研究的174名婴儿中,123名接受了产前类固醇治疗。其中,50名接受了1疗程,29名接受了≥2疗程的倍他米松治疗。两组围产期人口统计学特征无显著差异。在控制混杂变量后,两组之间的平均绝对波潜伏期、平均峰间潜伏期或反应类型分布均无显著差异。接受1疗程倍他米松治疗的婴儿(n = 50)和接受>2疗程倍他米松治疗的婴儿(n = 17)之间的任何听觉脑干反应参数也无显著差异。
与单一推荐疗程的产前类固醇相比,多疗程产前倍他米松对孕28至32周婴儿的听觉神经成熟度没有有害影响。